Mylene Morin
About Mylene Morin
Mylene Morin is an Associate in Clinical Operations at BeiGene with extensive experience in clinical trial research and a strong background in chemistry and molecular biology.
Title and Current Company
Mylene Morin currently holds the position of Associate in Clinical Operations at BeiGene. She contributes to clinical trial operations with a focus on oncology studies. Her role involves the development and implementation of clinical trial protocols, where she actively participates in ensuring regulatory compliance and adherence to Good Clinical Practice (GCP) guidelines.
Previous Roles at BeiGene
Before her current role, Mylene Morin worked as a Junior Associate in Clinical Operations at BeiGene from 2019 to 2021. During this time, she played a significant part in the successful completion of multiple Phase II and Phase III clinical trials. Moreover, she was involved in the training and mentoring of junior clinical operations staff, enhancing the team's overall proficiency.
Experience and Expertise
Mylene Morin has extensive experience in clinical trial research and management. She has worked at several reputable institutions, including the International Breast Cancer Study Group (IBCSG), where she served as a Project Manager in Clinical Trial Research. Morin also has a strong background in managing cross-functional teams and ensuring compliance with clinical regulations and standards.
Academic Background
Mylene Morin achieved her Ph.D. in Chemistry from the University of Zurich, where she researched for six years from 2012 to 2018. She also holds a Master’s degree in Molecular and Biological Chemistry from EPFL (École polytechnique fédérale de Lausanne) and a Bachelor of Applied Science (B.A.Sc.) in Chemistry and Chemical Engineering from the same institution. Additionally, she completed a Master’s thesis at the University of Toronto in 2012.
Research Contributions and Presentations
During her academic tenure, Mylene Morin presented her research findings at international conferences. Her contributions have been recognized in the academic community, particularly highlighted by her research work at the University of Zurich and her involvement in clinical trials and research projects at various organizations.